GeneDx CEO on pediatric genetic testing, future of genome sequencing and share surge
Katherine Stueland, GeneDx CEO, joins 'Closing Bell' to discuss company earnings and the future of genome sequencing.
Watsco Posts Upbeat Results, Joins GeneDx, Intel And Other Big Stocks Moving Higher On Tuesday
Watsco reported quarterly earnings of $2.37 per share which beat the analyst consensus estimate of $2.16 per share. The company reported quarterly sales of $1.75 billion which beat the analyst ...